The trial participants were administered an experimental medicine combined with Atezolizumab, an immunotherapy drug. Jasmin David David continues to have the drug every three weeks. By: ...
from Google Alert - health https://ift.tt/k3DXcQK
via IFTTT
0 comments:
Post a Comment